Michael Barnett
Michael Barnett
The University of Sydney / Brain and Mind Centre
Verified email at sydney.edu.au
TitleCited byYear
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ...
New England Journal of Medicine 367 (12), 1098-1107, 2012
12382012
Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion
MH Barnett, JW Prineas
Annals of Neurology 55 (4), 458-468, 2004
11812004
Multiple sclerosis: distribution of inflammatory cells in newly forming lesions
APD Henderson, MH Barnett, JDE Parratt, JW Prineas
Annals of neurology 66 (6), 739-753, 2009
3412009
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
CG Bien, A Vincent, MH Barnett, AJ Becker, M Blümcke, F Graus
Brain, 2012
3392012
Immunopathology of secondary‐progressive multiple sclerosis
JW Prineas, EE Kwon, ES Cho, LR Sharer, MH Barnett, EL Oleszak, ...
Annals of neurology 50 (5), 646-657, 2001
3172001
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis
V Devonshire, Y Lapierre, R Macdonell, C Ramo‐Tello, F Patti, ...
European journal of neurology 18 (1), 69-77, 2010
2942010
The evidence for a role of B cells in multiple sclerosis
G Disanto, JM Morahan, MH Barnett, G Giovannoni, SV Ramagopalan
Neurology 78 (11), 823-832, 2012
2122012
The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects
A Minagar, MH Barnett, RHB Benedict, D Pelletier, I Pirko, MA Sahraian, ...
Neurology 80 (2), 210-219, 2013
1992013
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
EK Mathey, SB Park, RAC Hughes, JD Pollard, PJ Armati, MH Barnett, ...
J Neurol Neurosurg Psychiatry 86 (9), 973-985, 2015
1962015
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
1562018
The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion
MH Barnett, APD Henderson, JW Prineas
Multiple sclerosis 12 (2), 121-132, 2006
1472006
CNS demyelination and quadrivalent HPV vaccination
I Sutton, R Lahoria, IL Tan, P Clouston, MH Barnett
Multiple Sclerosis Journal 15 (1), 116-119, 2009
1422009
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
S Ramanathan, SW Reddel, A Henderson, JDE Parratt, M Barnett, ...
Neurology-Neuroimmunology Neuroinflammation 1 (4), e40, 2014
1372014
The pathology of multiple sclerosis: a paradigm shift
MH Barnett, I Sutton
Current opinion in neurology 19 (3), 242-247, 2006
1302006
A follow up study of patients with paraneoplastic neurological disease in the United Kingdom
PM Candler, PE Hart, M Barnett, R Weil, JH Rees
Journal of Neurology, Neurosurgery & Psychiatry 75 (10), 1411-1415, 2004
1252004
Immunoglobulins and complement in postmortem multiple sclerosis tissue
MH Barnett, JDE Parratt, ES Cho, JW Prineas
Annals of neurology 65 (1), 32-46, 2009
1202009
Fingolimod after natalizumab and the risk of short-term relapse
VG Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, ...
Neurology 82 (14), 1204-1211, 2014
1192014
Fingolimod after natalizumab and the risk of short-term relapse
VG Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, ...
Neurology 82 (14), 1204-1211, 2014
1192014
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy
MH Barnett, JW Prineas, ME Buckland, JDE Parratt, JD Pollard
Multiple Sclerosis Journal, 2011
1192011
Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy
MH Barnett, JD Pollard, L Davies, JG McLeod
Muscle & Nerve: Official Journal of the American Association of …, 1998
1191998
The system can't perform the operation now. Try again later.
Articles 1–20